Speaker(s):

Stephen Kazmer, PharmD, Acute Care Clinical Pharmacist, Geisinger - has nothing to disclose

Moderator(s): 

Michael M O’Hara RPh, Centralized Clinical Pharmacy Services, Geisinger - has nothing to disclose.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

1. 1. • Review stigma and its effects
      • Review treatments specifically regarding opioid and alcohol use disorders

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Sarah F. Hale, PharmD, Daniel Longyhore, PharmD, Ed.D, BCACP, Michael M O’Hara RPh, and Mary Beth Mickel, CPhT have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None